Evidence map›Paper›PMID 28399397›Full record

ArticleDevelopmental cell2017

Genome Architecture from a Different Angle.

Elizabeth H Finn, Tom Misteli

Abstract readComment
In one paragraph

Article in Developmental cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Elizabeth H FinnNational Cancer Institute, NIH, Bethesda, MD 20892, USA.
Tom MisteliNational Cancer Institute, NIH, Bethesda, MD 20892, USA. Electronic address: mistelit@mail.nih.gov.

Funding

Nuclear Architecture and DiseaseZIABC010309 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MISTELI, THOMAS A · 2009 to 2025
$39.8M
Intramural NIH HHS ZIA BC010309
6 · The paper itself

Abstract

The study of genome architecture has recently been advanced by new techniques combining nuclear proximity ligation and high-throughput sequencing, but independent methods to validate them have been lacking. Reporting in Nature, Beagrie et al. (2017) describe such an orthogonal technique, called genome architecture mapping, to map genomes in 3D space.

Indexed as

Chromosome MappingGenomeHigh-Throughput Nucleotide Sequencing

Identifiers

PMID28399397
PMCPMC6301035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.